Professor Xia Ling from Zhejiang University has dedicated over thirty years to virtual heart technology. His student, Deng Dongdong, took up the mantle and founded Xinyun Medical, bringing together an industry-academia-research team to develop cardiac digital twin technology tailored to the characteristics of the local population. This technology surpasses the limitations of conventional 3D image reconstruction by achieving functional simulation of myocardial electrophysiology from underlying mechanisms—non-invasively and precisely localizing arrhythmia reentry circuits with highly interpretable results. To date, four product lines have been established, including sudden death risk prediction and ventricular tachycardia ablation target localization. Clinical validation is underway at multiple leading cardiovascular centers, with excellent performance across multiple data sets. The company plans to advance medical device registration step by step, positioning itself as an electrophysiology surgery auxiliary localization tool, with long-term expansion into full-process digital twin services for all cardiac diseases.
